JP2014505662A5 - - Google Patents

Download PDF

Info

Publication number
JP2014505662A5
JP2014505662A5 JP2013539296A JP2013539296A JP2014505662A5 JP 2014505662 A5 JP2014505662 A5 JP 2014505662A5 JP 2013539296 A JP2013539296 A JP 2013539296A JP 2013539296 A JP2013539296 A JP 2013539296A JP 2014505662 A5 JP2014505662 A5 JP 2014505662A5
Authority
JP
Japan
Prior art keywords
group
cancer
alkyl
phenyl
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2013539296A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014505662A (ja
Filing date
Publication date
Priority claimed from EP10382314A external-priority patent/EP2465498A1/en
Application filed filed Critical
Publication of JP2014505662A publication Critical patent/JP2014505662A/ja
Publication of JP2014505662A5 publication Critical patent/JP2014505662A5/ja
Pending legal-status Critical Current

Links

JP2013539296A 2010-11-23 2011-11-22 ジフェニル−アミン誘導体:使用、合成方法および医薬組成物 Pending JP2014505662A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP10382314A EP2465498A1 (en) 2010-11-23 2010-11-23 Diphenyl-amine derivatives: uses, process of synthesis and pharmaceutical compositions
EP10382314.2 2010-11-23
PCT/EP2011/070620 WO2012069442A1 (en) 2010-11-23 2011-11-22 Diphenyl-amine derivatives: uses, process of synthesis and pharmaceutical compositions

Publications (2)

Publication Number Publication Date
JP2014505662A JP2014505662A (ja) 2014-03-06
JP2014505662A5 true JP2014505662A5 (enExample) 2015-01-15

Family

ID=43971102

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013539296A Pending JP2014505662A (ja) 2010-11-23 2011-11-22 ジフェニル−アミン誘導体:使用、合成方法および医薬組成物

Country Status (17)

Country Link
US (1) US20130296346A1 (enExample)
EP (2) EP2465498A1 (enExample)
JP (1) JP2014505662A (enExample)
KR (1) KR20130121888A (enExample)
CN (1) CN103313707A (enExample)
AU (1) AU2011333887A1 (enExample)
BR (1) BR112013012665A2 (enExample)
CA (1) CA2818842A1 (enExample)
CL (1) CL2013001445A1 (enExample)
CO (1) CO6771413A2 (enExample)
MA (1) MA34746B1 (enExample)
MX (1) MX2013005761A (enExample)
RU (1) RU2013128602A (enExample)
SA (1) SA111320943B1 (enExample)
UY (1) UY33745A (enExample)
WO (1) WO2012069442A1 (enExample)
ZA (1) ZA201303692B (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RS51423B (sr) 2006-03-31 2011-02-28 Janssen Pharmaceutica N.V. Benzoimidazol-2-il pirimidini i pirazini kao modulatori histaminskog h4 receptora
US9371311B2 (en) 2008-06-30 2016-06-21 Janssen Pharmaceutica Nv Benzoimidazol-2-yl pyrimidine derivatives
JP6038882B2 (ja) * 2011-04-20 2016-12-07 マッパー・リソグラフィー・アイピー・ビー.ブイ. 光ファイバの構成体及びこのような構成体を形成する方法
JO3516B1 (ar) 2013-03-06 2020-07-05 Janssen Pharmaceutica Nv مُعدِّلات بنزإيميدازول-2-يل بيريميدين لمستقبل الهستامين h4
KR101694318B1 (ko) * 2014-10-02 2017-01-09 한국과학기술연구원 신규한 퓨린 유도체 및 이를 포함하는 암의 예방 또는 치료용 약학 조성물

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB682160A (en) * 1948-10-18 1952-11-05 Wellcome Found Improvements in and relating to the preparation of substituted aminoalcohols, alkenylamines, aminoalkanes and quaternary salts thereof
US6087346A (en) * 1993-06-23 2000-07-11 Cambridge Neuroscience, Inc. Sigma receptor ligands and the use thereof
US5795756A (en) 1995-12-11 1998-08-18 Johnson; Roger A. Method and compounds for the inhibition of adenylyl cyclase
CA2243330A1 (en) * 1996-01-20 1997-07-24 Ioana Popa Tamoxifen and analogues thereof
DE19756261A1 (de) * 1997-12-17 1999-07-01 Klinge Co Chem Pharm Fab Neue arylsubstituierte Pyridylalkan-, alken- und alkincarbonsäureamide
EP1375502B1 (en) 2001-04-05 2007-06-13 Sumitomo Chemical Company, Limited Process for producing 2,6-dihalogenopurine
US20050065171A1 (en) 2003-06-25 2005-03-24 Shakespeare William C. Substituted purine derivatives

Similar Documents

Publication Publication Date Title
KR101883125B1 (ko) 피리딘 아미도피리미딘 유도체, 그의 제조 방법 및 용도
KR101917972B1 (ko) ERK 억제제로서 티에노[2,3-c]피롤-4-온 유도체
RU2018100142A (ru) Гетероциклические соединения, эффективные для ингибирования киназы
JP2020517616A5 (enExample)
JP2014524441A5 (enExample)
JP2009534408A5 (enExample)
JP2014505662A5 (enExample)
JP2011522889A5 (enExample)
RU2017140639A (ru) Ингибиторы активности киназы lrrk2
RU2016118753A (ru) Производные пиридилкетона, способ их получения и их фармацевтическое применение
JP2008535902A5 (enExample)
JP2016523270A5 (enExample)
HRP20230472T1 (hr) Novi derivati hidroksikiseline, postupak njihove priprave i farmaceutski sastavi koji ih sadrže
CN107548391A (zh) 嘧啶或吡啶类化合物、其制备方法和医药用途
JP2016525075A5 (enExample)
EP2200437A1 (en) Tricyclic compounds having cytostatic and/or cytotoxic activity and methods of use thereof
RU2006131591A (ru) Способ получения 2-аминотиазол-5-ароматических карбоксамидов в качестве ингибиторов киназ
RU2005122901A (ru) Производные пиридино [2,3-] пиримидина в качестве селективных ингибиторов kdr и fgfr
JP2009511490A5 (enExample)
JP2013502441A5 (enExample)
JP2016514719A5 (enExample)
RU2012148246A (ru) 5, 7- замещенные-имидазо[1, 2-с]пиримидины как ингибиторы jak-киназ
CN114430740A (zh) Egfr抑制剂、组合物及其制备方法
JP2017532360A5 (enExample)
JPWO2023099624A5 (enExample)